Clinical trialNCT00607971TerminatedPhase 3Interventional

Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

SponsorAlizymeEnrollment939Constipation-Predominant Irritable Bowel Syndrome

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Anthony Lembo, MD
Beth Israel Deaconess Medical Center, Boston
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

126 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Huntsville, Alabama, United States
Research Site
Chandler, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Sierra Vista, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
North Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Burbank, California, United States
Research Site
Carmichael, California, United States
Research Site
Cerritos, California, United States
Research Site
Chula Vista, California, United States
Research Site
Cypress, California, United States
Research Site
Laguna Hills, California, United States
Research Site
Los Angeles, California, United States
Research Site
Orange, California, United States
Research Site
Orange, California, United States
Research Site
San Carlos, California, United States
Research Site
San Diego, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Lakewood, Colorado, United States
Research Site
Littleton, Colorado, United States
Research Site
Bristol, Connecticut, United States
Research Site
Boynton Beach, Florida, United States
Research Site
Coral Gables, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Inverness, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Kissimmee, Florida, United States
Research Site
Miami, Florida, United States
Research Site
New Port Richey, Florida, United States
Research Site
Palm Harbor, Florida, United States
Research Site
Pembrook Pines, Florida, United States
Research Site
Pensacola, Florida, United States
Research Site
Plantation, Florida, United States
Research Site
Port Orange, Florida, United States

86 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2006
Primary completion: 30 Jun 2008
Completion: 30 Jun 2008
Last update posted: 8 Jul 2008
Registered enrollment: 939
Registry id: NCT00607971

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.